First, let me say thank you to all of the healthcare workers who are putting themselves at risk during this crisis.
As I noted last week, many of the crucial issues for our healthcare system will remain after we all get through this challenging period. In that regard, here’s a look at some noteworthy news from the past month:
- Sanofi discloses new data about insulin prices
- Excellent new academic research on list vs. net drug prices
- Three notable researchers overturn their earlier research on drug costs
- Amazon switches PBM vendors for some of its employees
Plus, we unveil the teaser trailer for Drug Channels Video!
P.S. Join the more than 9,000 followers of my daily links to neat stuff at @DrugChannels on Twitter. My recent tweets have highlighted such topics as:
- How GoodRx shares patients’ prescription data
- 2019 drug trend at Prime Therapeutics
- Controversy about the independent pharmacy market
- A new $5 generic mail order program, Medicare Part D reform
- Retail pharmacy’s future
- Job openings at Amazon
- Frozen cookie dough
- And much more!
I have also been tweeting many under-the-radar stories about how the coronavirus affects drug channels.
Read more »
Source: Post feed
